Interpace Diagnostics (IDXG) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
August 9, 2018 4:47 PM EDTRevenue Grew 43% Over the Prior Years Quarter and 14% Over the Prior Period
Record Quarterly Revenue of $5.5 Million
Cash & Cash Equivalents of $10.1 Million with No Long-Term Debt
Now Covered by 27 Regional Blue Cross/Blue Shield Plan for ThyGenX® and ThyraMIR®
Company Successfully Launched New Mutational Panel for Thyroid: ThyGeNEXT
Guidance of Revenues for the Year of Over $20 Million Reaffirmed
Conference Call Thursday August 9, 2018 at 4:30 pm ET
Parsippany, NJ, Aug. 09, 2018 (GLOBE NEWSWIRE) --... More
